Printer Friendly

Mealey's begins Thimerosal & Vaccines report.

Last month we reported mat Mealey's was keeping up its pace of launching a new litigation title practically every month this year. Still maintaining that pace, Mealey Publications & Conferences Group, a member of LexisNexis, this month introduced Mealey's Litigation Report: ThimerosaL & Vaccines.

Marketing manager Lex Daniele said, "One of the hottest areas in drug product liability litigation today concerns the use of thimerosal in vaccines. A number of lawsuits have been filed across the country regarding this mercury-containing preservative. These lawsuits assert a variety of resulting illnesses, the most prominent or which is autism."

The new monthly report- priced at $800/year-covers recently filed lawsuits, the latest unearthed discovery, updates on medical studies, defenses, novel theories of recovery, medical monitoring claims, vaccine industry briefs, and more.

The report tracks important litigation news as it occurs in state and federal trial courts, as well as the National Vaccine Injury Compensation Program.

An online version and e-mail delivery are also available.

Mealey's publishes more than 40 litigation reports.

P.O. Box 62090. King of Prussia, PA 19406, 610- 768-7800, fax 610-768-0880,
COPYRIGHT 2002 The Newsletter on Newsletters LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:The Newsletter on Newsletters
Date:Jul 31, 2002
Previous Article:Phillips investment unveils (Launches).
Next Article:Four publishers offer insights into running a business in uncertain times. (Management).

Related Articles
Child-vaccine preservative prompts surge in mercury-poisoning claims.
Mealey to launch Litigation Report on Thimerosal & Vaccines.
Grand illusion.
Measuring risk: vaccines save lives, but also cause health problems. (Your Health).
Injecting mercury: is thimerosal the missing link to autism and developmental problems?
Thimerosal plaintiffs push on despite setbacks.
Fifth Circuit allows case against thimerosal maker to proceed.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters